The office of the National Cancer Registry is closed due to government advice relating to Coronavirus.
Effective from the 16th March, employees are working remotely and can be contacted via email.
Please be advised that until the office reopens all FOI requests and SAR’s should be sent via email, as requests made via post may receive a delayed response.
The office will remain closed until further notice.
| Cancer | Years | Method | Sex | Age | Survived | Net survival | 95% lower | 95% upper |
|---|---|---|---|---|---|---|---|---|
| All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 1.00 years | 77.4% | 77.1% | 77.7% |
| All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 5.00 years | 62.4% | 62.0% | 62.8% |
| All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 10.00 years | 58.5% | 57.9% | 59.2% |
| All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 1.00 years | 76.8% | 76.4% | 77.2% |
| All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 5.00 years | 62.4% | 61.9% | 63.0% |
| All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 10.00 years | 59.1% | 58.1% | 60.2% |
| All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 1.00 years | 78.1% | 77.7% | 78.5% |
| All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 5.00 years | 62.4% | 61.8% | 62.9% |
| All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 10.00 years | 57.9% | 57.1% | 58.7% |
Printer-friendly version